These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22415182)

  • 1. Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico.
    Arredondo A; Zuñiga A
    Cad Saude Publica; 2012 Mar; 28(3):497-502. PubMed ID: 22415182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.
    Arredondo A; Duarte MB; Cuadra SM
    Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A; Parada I
    Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A
    Am J Hypertens; 2006 Jun; 19(6):553-9. PubMed ID: 16733225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.
    Arredondo A; Cuadra SM; Duarte MB
    BMC Public Health; 2015 Nov; 15():1106. PubMed ID: 26546356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cost of diabetes in Latin America: evidence from Mexico].
    Arredondo A; De Icaza E
    Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.
    Arredondo A; Aviles R
    PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
    Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
    Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
    Arredondo A
    Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends for the management of hypertension in older adults in Latin America in the context of universal coverage: Evidence from Mexico.
    Arredondo A; Recamán AL; Suarez-Herrera JC; Cuadra SM
    Int J Health Plann Manage; 2021 Mar; 36(2):579-586. PubMed ID: 33368667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
    Arredondo A; Zúñiga A
    Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Epidemiological changes and economic burden of hypertension in Latin America: evidence from Mexico".
    Barceló A
    Am J Hypertens; 2006 Jun; 19(6):551-2. PubMed ID: 16733224
    [No Abstract]   [Full Text] [Related]  

  • 13. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
    Arredondo A; Reyes G
    PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and financial consequences of the changing epidemiological profile in Mexico.
    Arredondo A
    Health Policy; 1997 Oct; 42(1):39-48. PubMed ID: 10173492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of expected epidemiological changes in diseases related to tobacco, Mexico.
    Arredondo A; Carrillo C; Zuñiga A
    Rev Saude Publica; 2007 Aug; 41(4):523-9. PubMed ID: 17589749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
    Arredondo A; Azar A; Recamán AL
    Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
    Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
    Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial consequences of changes in health care demands related to tobacco consumption in Mexico: information for policy makers.
    Arredondo A; Parada I; Carrillo C
    Health Policy; 2002 Jul; 61(1):43-55. PubMed ID: 12173496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High blood pressure in Latin America: a call to action.
    Rubinstein A; Alcocer L; Chagas A
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):259-85. PubMed ID: 19561117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breastfeeding promotion and priority setting in health.
    Horton S; Sanghvi T; Phillips M; Fiedler J; Perez-Escamilla R; Lutter C; Rivera A; Segall-Correa AM
    Health Policy Plan; 1996 Jun; 11(2):156-68. PubMed ID: 10158457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.